The SerOptix process involves the capture of an emitted fluorescence spectra, with the pattern of emission assessed by analysis of specified spectral parameters. The spectral readings of blood samples are compared to models of infected and normal plasma and quickly identified as diseased or healthy.


Discrimination Between HCV-Positive and Normal Human Plasma
by Measurement of Intrinsic Fluorescence
(HCV/ID-LBS Assay)

[ About SerOptix ] [ The SerOptix Process ]
[ Investment News ] [ Industry News ] [ Media ]
[ Career Opportunities ] [ Contact Us ][ Home ]

Copyright© 2000 SerOptix,Inc
All Rights Reserved